Treatment of resectable gastric cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Therapeutic Advances in Gastroenterology

• Publication date

  2012-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1756283X11410771PMID 22282708PMCID PMC3263979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: Randomized EORTC phase III trial #40954.

  2016cited by this paper
• Epidemiology and Risk Factors

  2011cited by this paper
• Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

  2010cited by this paper
• The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions.

  2010cited by this paper
• Morbidity and Mortality of Laparoscopic Gastrectomy Versus Open Gastrectomy for Gastric Cancer: An Interim Report—A Phase III Multicenter, Prospective, Randomized Trial (KLASS Trial)

  2010cited by this paper
• Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram

  2010cited by this paper
• Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

  2010cited by this paper
• Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.

  2010cited by this paper
• Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

  2010cited by this paper
• Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.

  2010cited by this paper
• Gastric Cancer: Epidemiology and Risk Factors

  2010cited by this paper
• Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

  2010cited by this paper
• Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis.

  2009cited by this paper
• Meta‐analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

  2009cited by this paper
• Trends in incidence of oesophageal and stomach cancer subtypes in Europe

  2009cited by this paper
• Hereditary diffuse gastric cancer: A manifestation of lost cell polarity

  2009cited by this paper
• EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

  2009cited by this paper
• Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study

  2009cited by this paper
• Chemoradiation of resected gastric cancer: A 10-year follow-up of the phase III trial INT0116 (SWOG 9008).

  2009cited by this paper
• Stomach Carcinoma Incidence Patterns in the United States by Histologic Type and Anatomic Site

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Survival after radiotherapy in gastric cancer: systematic review and meta-analysis.

  2009influential reference
• Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains.

  2008cited by this paper
• Obesity and diabetes epidemics: cancer repercussions.

  2008cited by this paper
• The Japanese guidelines for gastric cancer screening.

  2008cited by this paper
• The difficult choice between total and proximal gastrectomy in proximal early gastric cancer.

  2008cited by this paper
• A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma.

  2008cited by this paper
• Postoperative adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer: A randomized phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short- term doxifluridine (Mf) (AMC 0101) (NCT00296322

  2008cited by this paper
• A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201) (NCT00296335)

  2008cited by this paper
• D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

  2008cited by this paper
• Smoking and gastric cancer: systematic review and meta-analysis of cohort studies

  2008cited by this paper
• A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer

  2007cited by this paper
• Diet and the risk of gastric cancer: review of epidemiological evidence

  2007cited by this paper
• Does Graded Histologic Response After Neoadjuvant Chemotherapy Predict Survival for Completely Resected Gastric Cancer?

  2007cited by this paper
• Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study

  2007cited by this paper
• Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer

  2007cited by this paper
• Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy

  2007cited by this paper
• Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

  2007cited by this paper
• Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

  2007cited by this paper
• Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status

  2007cited by this paper
• Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial

  2007cited by this paper
• Current status of minimal access surgery for gastric cancer.

  2007cited by this paper
• Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15‐year experience at a single institute

  2007cited by this paper
• Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

  2007cited by this paper
• A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.

  2007cited by this paper
• Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.

  2007cited by this paper
• Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).

  2007cited by this paper
• Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support.

  2007cited by this paper
• The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

  2007influential reference
• Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006cited by this paper
• Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?

  2006cited by this paper
• Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

  2006cited by this paper
• Nodal dissection for patients with gastric cancer: a randomised controlled trial.

  2006cited by this paper
• Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence.

  2006cited by this paper
• Gastric Cancer Clinical Practice Guidelines.

  2006cited by this paper
• Laparoscopic gastrectomy with lymph node dissection for gastric cancer

  2006cited by this paper
• Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

  2006cited by this paper
• Fruits, Vegetables, and Antioxidants and Risk of Gastric Cancer among Male Smokers

  2005cited by this paper
• Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric Cancer: Five-Year Results of a Randomized Prospective Trial

  2005cited by this paper
• Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial.

  2005cited by this paper
• The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

  2005cited by this paper
• Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.

  2005cited by this paper
• Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.

  2005cited by this paper
• Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

  2005cited by this paper
• A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results

  2005cited by this paper
• An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

  2005cited by this paper
• Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer

  2005cited by this paper
• Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.

  2004cited by this paper
• Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma

  2004cited by this paper
• Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.

  2004cited by this paper
• Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

  2004cited by this paper
• Model of the early development of diffuse gastric cancer in E‐cadherin mutation carriers and its implications for patient screening

  2004cited by this paper
• Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

  2004influential reference
• Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan

  2004cited by this paper
• Gastric cancer epidemiology and risk factors.

  2003cited by this paper
• Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report

  2002cited by this paper
• A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report.

  2002cited by this paper
• Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group.

  2002cited by this paper
• Chemotherapy in gastric cancer: a review and updated meta-analysis.

  2002cited by this paper
• Concentrated preoperative radiotherapy for resectable gastric cancer: 20‐years follow‐up of a randomized trial

  2002cited by this paper
• Gastric cancer--patterns of relapse after surgical resection.

  2002cited by this paper
• Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

  2002cited by this paper
• Gastric cancer treatment guidelines in Japan

  2002cited by this paper
• Principles of surgical radicality in the treatment of gastric cancer.

  2001cited by this paper
• Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial.

  2001cited by this paper
• Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial

  2001cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001influential reference
• Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

  2001cited by this paper
• The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy

  2000cited by this paper
• Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients

  2000cited by this paper
• Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

  2000cited by this paper
• Very high risk of cancer in familial Peutz-Jeghers syndrome.

  2000cited by this paper
• Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1,002 Consecutive Patients

  2000cited by this paper
• A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer.

  2000cited by this paper
• Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

  1999cited by this paper
• [Extended lymph-node dissection for gastric cancer].

  1999cited by this paper
• Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

  1999cited by this paper

• Prognostic value of the lactate-based modified cally score in postoperative gastric cancer patients admitted to the ICU.

  2026cites this paper
• Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities

  2024influential citation
• Locally Advanced Gastric Cancer Management: A Cost-Effectiveness Analysis

  2024cites this paper
• Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an o-methoxy phenyl group as potential agents against gastric cancer

  2024cites this paper
• Survival and Recurrence Patterns in Patients With Stomach Adenocarcinoma Receiving Chemotherapy or Chemoradiotherapy After D2 Gastrectomy in a Tertiary Care Cancer Institute: A Retrospective Real-World Evidence Cohort Study

  2023cites this paper
• Prognostication of tumor progression in radically operated stage IIB-IIIC cancer patients after undergoing adjuvant perfusion thermochemotherapy

  2022cites this paper
• Targeting Wnt/β-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer

  2022cites this paper
• Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma

  2022cites this paper
• CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer

  2022cites this paper
• The Discordance of Clinical and Pathologic Staging in Locally Advanced Gastric Adenocarcinoma

  2021cites this paper
• Observation of efficacy and prognosis of chemoradiotherapy with apatinib in combination with oxaliplatin + 5-fluorouracil + leucovorin in the gastric cancer in advanced stage

  2021cites this paper
• Ближайшие и отдаленные результаты проксимальной резекции желудка в зависимости от способов восстановления непрерывности пищеварительного тракта

  2021cites this paper
• Development and validation of an individual alternative splicing prognostic signature in gastric cancer

  2021cites this paper
• Clinicopathological Characteristics of Gastric Cancer in Iranian Patients Referred to Imam Reza Hospital During 2008 to 2017

  2020cites this paper
• Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer

  2020cites this paper
• A DNA methylation signature to improve survival prediction of gastric cancer

  2020cites this paper
• Cod Skin Oligopeptide Inhibits Human Gastric Carcinoma Cell Growth by Inducing Apoptosis

  2020cites this paper
• Does Neoadjuvant Chemotherapy Increase the Survival in Patients with Locally Advanced Gastric Cancer Patients? – A Real‑World Evidence

  2020cites this paper
• A novel lymph node staging system for gastric cancer including modified Union for cancer Control/American Joint Committee on cancer and Japanese Gastric Cancer Association criteria.

  2020cites this paper
• Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer

  2020cites this paper
• Propofol-based total intravenous anesthesia improves survival compared to desflurane anesthesia in gastric cancer surgery

  2020cites this paper
• High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients

  2019cites this paper
• An appraisal of result of surgery for gastric carcinoma

  2019cites this paper
• Alantolactone induces gastric cancer BGC-823 cell apoptosis by regulating reactive oxygen species generation and the AKT signaling pathway

  2019cites this paper
• Laparoscopic Surgery for Gastric Cancer: Distal Subtotal Gastrectomy with D2 Lymph Node Dissection

  2019cites this paper
• Comparison of FDG-PET/CT for Cancer Detection in Populations With Different Risks of Underlying Malignancy

  2019cites this paper
• CD133 Expression as a Helicobacter pylori-independent Biomarker of Gastric Cancer Progression

  2018cites this paper
• Expression of E-cadherin and Ki-67 in Gastric Cancer Patients and Correlation with Clinicopathological Factors

  2018cites this paper
• Enhancing the anti-gastric cancer activity of curcumin with biocompatible and pH sensitive PMMA-AA/ZnO nanoparticles.

  2018cites this paper
• Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study

  2017cites this paper
• How to stomach an epigenetic insult: the gastric cancer epigenome

  2017cites this paper
• Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis

  2017cites this paper
• Beneficial Effect of Educational and Nutritional Intervention on the Nutritional Status and Compliance of Gastric Cancer Patients Undergoing Chemotherapy: A Randomized Trial

  2017cites this paper
• Biocompatible curcumin loaded PMMA-PEG/ZnO nanocomposite induce apoptosis and cytotoxicity in human gastric cancer cells.

  2017cites this paper
• Stage Association of Preoperative Serum Carcinoembryonic Antigen with Gastric Adenocarcinoma in Iranian Patients

  2017cites this paper
• Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach

  2017cites this paper
• Examining the gastric cancer survival gap between Asians and whites in the United States

  2017cites this paper
• Sijunzi decoction-treated rat serum induces apoptosis of side population cells in gastric carcinoma.

  2017cites this paper
• Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer

  2017cites this paper
• Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis

  2016influential citation
• C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.

  2016cites this paper
• Evaluation of Response to Preoperative Chemotherapy Versus Surgery Alone in Gastroesophageal Cancer: Tumor Resectability, Pathologic Results and Post-Operative Complications.

  2016cites this paper
• Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms

  2016cites this paper
• The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy

  2016cites this paper
• Current Concepts in Gastric Signet Ring Cell Carcinoma

  2015cites this paper
• A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer

  2015cites this paper
• Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer.

  2015cites this paper
• Advanced Gastric Cancer with Liver and Lymph Node Metastases Successfully Resected after Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil

  2015cites this paper
• A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma

  2015cites this paper
• TOTALLY LAPAROSCOPIC DISTAL GASTRECTOMY WITH D2 LYMPH NODE DISSECTION BASED ON JAPANESE GASTRIC CANCER TREATMENT GUIDELINES: PRINCIPLES AND METHODS

  2015cites this paper
• Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer.

  2015cites this paper
• ACR Appropriateness Criteria® Resectable Stomach Cancer.

  2015influential citation
• Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity

  2015cites this paper
• In vitro analysis of the role of the mitochondrial apoptosis pathway in CSBE therapy against human gastric cancer.

  2015cites this paper
• Технические аспекты лапароскопической дистальной резекции желудка с D2-лимфодиссекцией

  2015cites this paper
• Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model.

  2015cites this paper
• Protein-protein interactions of the nuclear receptor NR4A2

  2014cites this paper
• Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study

  2014cites this paper
• Current role of minimally invasive approaches in the treatment of early gastric cancer.

  2014cites this paper
• Implications of inadequate lymph node staging in resectable gastric cancer: A contemporary analysis using the National Cancer Data Base

  2014cites this paper
• Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis

  2014cites this paper
• Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.

  2014cites this paper
• Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Disease-Specific Survival after R0 Resection in a Chinese Gastric Cancer Population

  2013cites this paper
• A Multidisciplinary Approach to the Treatment of Gastric Cancer: What Is the Role of the Surgeon?

  2013cites this paper
• Enhanced RegIV Expression Predicts the Intrinsic 5-Fluorouracil (5-FU) Resistance in Advanced Gastric Cancer

  2013cites this paper
• Sinomenine sensitizes gastric cancer cells to 5-fluorouracil in vitro and in vivo

  2013cites this paper
• Alpinetin promotes Bax translocation, induces apoptosis through the mitochondrial pathway and arrests human gastric cancer cells at the G2/M phase.

  2013cites this paper
• Surgical Treatment of Liver Metastases from Gastric Cancer

  2013cites this paper
• A Study of Gastric Cancer Cases with Liver Metastasis

  2013cites this paper
• A phase II study of preoperative chemotherapy with modified FOLFOX6 followed by surgery and postoperative chemoradiation in patients with localized gastric adenocarcinoma.

  2013cites this paper
• Gastric cancer: past accomplishments, present approaches and future aspirations

  2013cites this paper
• Surgical treatment of liver metastases of gastric cancer: state of the art

  2012cites this paper
• β,β-Dimethylacrylshikonin exerts antitumor activity via Notch-1 signaling pathway in vitro and in vivo.

  2012cites this paper
• Knowledge and Attitudes of Junior Medical Doctors towards Gastric Cancer

  2012cites this paper
• E‐cadherin dysfunction in gastric cancer ‐ Cellular consequences, clinical applications and open questions

  2012cites this paper
• W1024 Knowledge and Attitudes of Junior Medical Doctors Towards Gastric Cancer

  2010cites this paper
• World Journal of Gastrointestinal Surgery

  year unknowncites this paper
• Acr Appropriateness Criteria® Resectable Stomach Cancer Acr Appropriateness Criteria® Resectable Stomach Cancer

  year unknowncites this paper